Eli Lilly reports 15% rise in quarterly sales

Eli Lilly and Co reported a 15.1% rise in first-quarter sales on Thursday, boosted by higher sales of its top-selling diabetes drug Trulicity and also benefiting from customers stockpiling its medicines amid the coronavirus pandemic.